Inventor · disambiguated record
Joseph Kent Barbay
Also filed as: BARBAY JOSEPH KENT
13 granted patents·9 pending applications·19 citations·filing 2008–2024
87Inventor score
Files withJANSSEN PHARMACEUTICA NV11JACKSON PAUL FRANCIS3LEONARD KRISTI A3BARBAY JOSEPH KENT2LEONARD KRISTI ANNE1
Top patents by PatentIndex Score
22 records- 0191US12065446B2Inhibitors of Bruton's tyrosine kinase and method of their useJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Aug 20, 2024·1 cites·4 claims
- 0291US10717745B2Inhibitors of Bruton's tyrosine kinase and method of their useJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Jul 21, 2020·5 cites·26 claims
- 0390US10954214B2Pyrazole derivatives as MALT1 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Mar 23, 2021·5 cites·37 claims
- 0490US10934310B2Inhibitors of Bruton's tyrosine kinase and method of their useJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Mar 2, 2021·4 cites·7 claims
- 0586US2024383914A1Inhibitors of bruton's tyrosine kinase and methods of their useJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 0684US11319329B2Inhibitors of Bruton's tyrosine kinase and methods of their useJANSSEN PHARMACEUTICA NV·Filed 2020·Granted May 3, 2022·1 cites·7 claims
- 0776US11040031B2Pyrazole derivatives as MALT1 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Jun 22, 2021·2 cites·9 claims
- 0865US10800792B2Inhibitors of Bruton's tyrosine kinase and method of their useJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Oct 13, 2020·0 cites·4 claims
- 0964US12077521B2Pyrazole derivatives as MALT1 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Sep 3, 2024·0 cites·18 claims
- 1064US10822348B2Inhibitors of Bruton's tyrosine kinase and methods of their useJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Nov 3, 2020·0 cites·10 claims
- 1163US8883473B2Methods of treatment using allosteric processing inhibitors for matrix metalloproteinasesLEONARD KRISTI A·Filed 2012·Granted Nov 11, 2014·1 cites·14 claims
- 1258US10689396B2Inhibitors of Bruton's tyrosine kinase and methods of their useJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Jun 23, 2020·0 cites·23 claims
- 1350US8798939B2Methods for designing, selecting and/or optimizing allosteric processing inhibitors for matrix metalloproteinasesLEONARD KRISTI A·Filed 2012·Granted Aug 5, 2014·0 cites·4 claims
- 1448US2009048295A1Substituted 5,6,7,8-tetrahydroquinoline derivatives, compositions, and methods of use thereofBARBAY JOSEPH KENT·Filed 2008·Application pending·0 cites
- 1540US2012302569A1Phenyl-thiazolyl inhibitors of pro-matrix metalloproteinase activationJACKSON PAUL FRANCIS·Filed 2012·Application pending·0 cites
- 1639US2012129843A1Pyridyl-thiazolyl inhibitors of pro-matrix metalloproteinase activationZHANG YAN·Filed 2011·Application pending·0 cites
- 1739US2012129872A1Fused heteroaryl inhibitors of pro-matrix metalloproteinase activationLEONARD KRISTI ANNE·Filed 2011·Application pending·0 cites
- 1839US2012129897A1Bis heteroaryl inhibitors of pro-matrix metalloproteinase activationBARBAY JOSEPH KENT·Filed 2011·Application pending·0 cites
- 1939US2012129842A1Bisthiazole inhibitors of pro-matrix metalloproteinase activationJACKSON PAUL FRANCIS·Filed 2011·Application pending·0 cites
- 2038US8753857B2Crystal structure of the pro form of a matrix metalloproteinase and an allosteric processing inhibitorLEONARD KRISTI A·Filed 2012·Granted Jun 17, 2014·0 cites·4 claims
- 2138US2012302573A1Methods of inhibiting pro matrix metalloproteinase activationJACKSON PAUL FRANCIS·Filed 2012·Application pending·0 cites
- 2238US2012129811A1Tricyclic inhibitors of pro-matrix metalloproteinase activationWANG AIHUA·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Joseph Kent Barbay files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →